ESTYBON Trademark

Trademark Overview

On Wednesday, September 23, 2009, a trademark application was filed for ESTYBON with the United States Patent and Trademark Office. The USPTO has given the ESTYBON trademark a serial number of 77833465. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 28, 2021. This trademark is owned by Onconova Therapeutics, Inc.. The ESTYBON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases
estybon

General Information

Serial Number77833465
Word MarkESTYBON
Filing DateWednesday, September 23, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 28, 2021
Registration Number3868532
Registration DateTuesday, October 26, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2010

Trademark Statements

Goods and Servicespharmaceuticals, namely, drugs for the treatment of cancer, myelodysplastic syndromes, ovarian cancer, pancreatic cancers, solid tumors, and hematological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 28, 2021
Primary Code005
First Use Anywhere DateTuesday, June 1, 2010
First Use In Commerce DateTuesday, June 1, 2010

Trademark Owner History

Party NameOnconova Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewtown, PA 18940
Party NameOnconova Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewtown, PA 18940
Party NameOnconova Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewtown, PA 18940

Trademark Events

Event DateEvent Description
Tuesday, March 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 28, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, October 26, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 21, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, October 11, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 11, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 4, 2016TEAS SECTION 8 & 15 RECEIVED
Monday, October 26, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 2, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 26, 2010REGISTERED-PRINCIPAL REGISTER
Friday, September 24, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 23, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, September 22, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 16, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 19, 2010USE AMENDMENT FILED
Thursday, September 16, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 19, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, June 15, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 13, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 11, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 11, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 11, 2010ASSIGNED TO LIE
Tuesday, February 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 20, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 20, 2009NON-FINAL ACTION E-MAILED
Sunday, December 20, 2009NON-FINAL ACTION WRITTEN
Saturday, December 19, 2009ASSIGNED TO EXAMINER
Monday, September 28, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

estybon cancer solid cancers tumors diseases hematological pancreatic syndromes drugs namely